GlassScriptPhysician profile
Hudnall Paschal
NPI 1659338986
$777.40
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $30.35.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $159.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $135.55 | 2019 | |
| Novo Nordisk INC | $79.48 | 2019-2020 | |
| Astellas Pharma US INC | $59.10 | 2019 | |
| Novartis Pharmaceuticals Corporation | $53.94 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $43.87 | 2019 | |
| Arbor Pharmaceuticals, INC. | $34.13 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.72 | 2019 | |
| Amgen INC. | $27.46 | 2019 | |
| Pfizer INC. | $22.22 | 2019 | |
| Boston Scientific Corporation | $18.60 | 2019 | |
| Mylan Specialty L.P. | $13.12 | 2019 | |
| Abbott Laboratories | $13.08 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.00 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.03 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $10.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hudnall Paschal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.